drugset / Trial / NCT06961747

A Study to Assess Zilucoplan Concentration in Breast Milk of Healthy Lactating Women

NCT06961747

Phase 1 Recruiting 15 enrolled UCB Biopharma SRL
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to assess the steady state (SS) concentrations of zilucoplan (ZLP) and its major metabolites in mature breast milk of healthy study participants following injection of repeated once-daily doses of ZLP.

Timeline

Start
2025-07-09
Primary completion
2027-03-23
Completion
2027-03-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Zilucoplan Peptide Subcutaneous

Indications

No indication recorded.